INSULIN LISPRO - Food and Drug Administration

Set ID: a42609d2-d76b-4c21-bc65-ace5fa0da69d
Type: Indexing - product concept
Effective date: 2021-01-05
Version: 1
Source: DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
Label	Relation	Manufacturer	Effective
These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Product name	A-S Medication Solutions	2026-09-18
These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Product name	REMEDYREPACK INC.	2026-09-03
These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Product name	Eli Lilly and Company	2026-07-27
These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Product name	Eli Lilly and Company	2026-06-16
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Product name	Eli Lilly and Company	2026-06-16
These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Product name	Eli Lilly and Company	2026-06-16
These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Product name	A-S Medication Solutions	2026-04-13
These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Product name	Eli Lilly and Company	2026-01-13
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Product name	Eli Lilly and Company	2026-01-09
These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Product name	Eli Lilly and Company	2025-12-30
These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Product name	REMEDYREPACK INC.	2025-10-01
These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Product name	Eli Lilly and Company	2025-06-17
These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Product name	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH	2025-06-04
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Product name	A-S Medication Solutions	2025-04-01
These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Product name	Eli Lilly and Company	2024-08-06
These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG ® Mix75/25™ (insulin lispro protamine and insulin lispro).	Product name	Eli Lilly and Company	2024-08-06
These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG® (insulin lispro).	Product name	A-S Medication Solutions	2024-05-31
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Product name	A-S Medication Solutions	2024-02-15
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Product name	A-S Medication Solutions	2024-01-24
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Product name	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2012-09-27
These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Product name	Physicians Total Care, Inc.	2012-05-22
HUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)	Product name	Physicians Total Care, Inc.	2011-12-20

NDC, DailyMed label, Manufacturer table
NDC	DailyMed label	Manufacturer
0002-0800	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-0800-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7510	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Dispensing Solutions, Inc. \| PSS World Medical, Inc.
0002-7510	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
0002-7510	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
0002-7510	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
0002-7510	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7510-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7510-17	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7510-99	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7511	HUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)	Physicians Total Care, Inc.
0002-7511	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-7511-01	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-7512	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-7512-01	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-7512-99	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-7516	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
0002-7516	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7516-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7516-59	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7516-99	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7533	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7533-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7712	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7712-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7712-27	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7712-61	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7714	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7714-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7714-59	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7714-61	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-7726	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7726-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7726-05	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7728	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7728	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	A-S Medication Solutions
0002-7728-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7728-99	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-7737	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG® (insulin lispro).	A-S Medication Solutions
0002-7737	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-7737	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	A-S Medication Solutions
0002-7737-01	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-7752	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-7752-01	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-7752-05	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-8207	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8207-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8207-05	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8207-61	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8208	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8208-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8208-27	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8213	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8213-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8213-05	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8222	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-8222-01	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-8222-59	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	Eli Lilly and Company
0002-8228	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8228-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8228-27	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8233	These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG ® Mix75/25™ (insulin lispro protamine and insulin lispro).	Eli Lilly and Company
0002-8233-01	These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG ® Mix75/25™ (insulin lispro protamine and insulin lispro).	Eli Lilly and Company
0002-8233-05	These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG ® Mix75/25™ (insulin lispro protamine and insulin lispro).	Eli Lilly and Company
0002-8235	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8235-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8235-05	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8235-99	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8351	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8351-01	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8351-05	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	Eli Lilly and Company
0002-8725	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
0002-8797	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8797-01	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8797-59	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8797-61	These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8798	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8798-01	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8798-59	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8798-99	These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999	Eli Lilly and Company
0002-8799	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8799	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
0002-8799	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
0002-8799-01	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8799-59	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0002-8799-61	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	Eli Lilly and Company
0024-5924	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5924-10	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5925	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	REMEDYREPACK INC.
0024-5925	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5925-00	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5925-01	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5925-05	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5926	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
0024-5926-05	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	Sanofi-Aventis U.S. LLC \| Sanofi-Aventis Deutschland GmbH
50090-1375	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-1375-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-1663	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-1663-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-4073	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-4073-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-4488	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-4488-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996	A-S Medication Solutions
50090-5391	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	A-S Medication Solutions
50090-5391	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG® (insulin lispro).	A-S Medication Solutions
50090-5391-0	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).	A-S Medication Solutions
50090-5391-0	These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG® (insulin lispro).	A-S Medication Solutions
50090-7433	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	A-S Medication Solutions
50090-7433-0	These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020	A-S Medication Solutions
54868-4381	HUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)	Physicians Total Care, Inc.
54868-4381-0	HUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100)	Physicians Total Care, Inc.
54868-5108	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
54868-5108-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
54868-5836	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
54868-5836-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
54868-5899	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
54868-5899-0	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Physicians Total Care, Inc.
55045-3602	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Dispensing Solutions, Inc. \| PSS World Medical, Inc.
55045-3602-1	These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996	Dispensing Solutions, Inc. \| PSS World Medical, Inc.
70518-4275	These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	REMEDYREPACK INC.

INSULIN LISPRO - Food and Drug Administration

Mapped DailyMed Labels#

Related NDC Packages#